BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27371345)

  • 1. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
    Gray JM; Ameduri RK
    Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
    Myers JN; Shabshab SF; Burton NA; Nathan SD
    J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
    Abraham KA; Little MA; Dorman AM; Walshe JJ
    Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
    Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
    Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation.
    Furmańczyk A; Komuda-Leszek E; Durlik M
    Ann Transplant; 2009; 14(4):47-51. PubMed ID: 20009155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
    Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
    Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
    Pratap B; Abraham G; Srinivas CN; Bhaskar S
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
    Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
    Transpl Int; 1998; 11 Suppl 1():S98-9. PubMed ID: 9664954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.
    Rerolle JP; Akposso K; Lerolle N; Mougenot B; Ponnelle T; Rondeau E; Sraer JD
    Clin Transplant; 2000 Jun; 14(3):262-5. PubMed ID: 10831087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient.
    Shitrit D; Starobin D; Aravot D; Fink G; Izbicki G; Kramer M
    Transplant Proc; 2003 Mar; 35(2):627-8. PubMed ID: 12644073
    [No Abstract]   [Full Text] [Related]  

  • 14. Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation.
    Parissis H; Gould K; Dark J
    J Cardiothorac Surg; 2010 Sep; 5():70. PubMed ID: 20813025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
    J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic uremic syndrome in solid-organ transplant recipients.
    Singh N; Gayowski T; Marino IR
    Transpl Int; 1996; 9(1):68-75. PubMed ID: 8748414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemolytic uremic syndrome due to sirolimus in a heart transplant recipient. Case report].
    Izquierdo MT; Almenar L; Martínez-Dolz L; Moro JA
    Rev Esp Cardiol; 2007 Jan; 60(1):85-6. PubMed ID: 17288963
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic and uremic syndrome after heart transplantation.
    Mercadal L; Petitclerc T; Assogba U; Beaufils H; Deray G
    Am J Nephrol; 2000; 20(5):418-20. PubMed ID: 11093002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient.
    Galli FC; Damon LE; Tomlanovich SJ; Keith F; Chatterjee K; DeMarco T
    J Heart Lung Transplant; 1993; 12(3):440-4. PubMed ID: 8329415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.